Effects of histamine H1- and H2-receptor antagonists on cardiovascular function during systemic anaphylaxis in guinea pigs.
The heart is a target organ of anaphylaxis. In isolated perfused hearts, an anaphylactic reaction is characterized by arrhythmias, coronary constriction and severe impairment of ventricular contractile force. Various mediators such as PAF, thromboxane A2 and leukotrienes are responsible for anaphylactic coronary constriction and negative inotropic effects. The cardiac effects of anaphylactic histamine release are related to the stimulation of two antagonistic receptor types. Histamine induces atrioventricular conduction delay and constriction of the epicardial coronary vessels via H1-receptor stimulation. H2-receptors, however, mediate coronary vasodilation and an increase in heart rate and myocardial contractility. It may therefore be concluded that administration of histamine H2-receptor antagonists is disadvantageous. During anaphylactic states, the cardiodepressive effects of the other mediators of anaphylaxis are unmasked, resulting in a sustained coronary constriction and impairment of myocardial contractility. To verify this speculation, we investigated the effects of H1- and H2-receptor antagonists on cardiovascular function of guinea pigs during systemic anaphylaxis. In guinea pigs, sensitization was produced by subcutaneous application of ovalbumin. Fourteen days after sensitization, the effects of an intravenous infusion of ovalbumin were tested in the anesthetized artificially ventilated guinea pigs. The renewed administration of the antigen induced severe cardiac dysfunction. Within a few minutes, cardiac output markedly decreased and left ventricular end-diastolic pressure increased significantly, indicating left ventricular pump failure. In the same time range, ECG recordings uniformly showed signs of acute myocardial ischemia. In addition, arrhythmias occurred in terms of an atrioventricular block.(ABSTRACT TRUNCATED AT 400 WORDS)
Department of Medicine I, Technische Universität München, W. Germany.
S B
SB
Felix
G
G
Baumann
M
M
Niemczyk
T
T
Hashemi
G
G
Ochsenfeld
Z
Z
Ahmad
S
S
Shirani
H
H
Blömer
D000707:Anaphylaxis / Q000276:immunology / Q000503:physiopathology*; D000818:Animals; D016589:Astemizole; D001562:Benzimidazoles / Q000494:pharmacology; D001794:Blood Pressure; D002302:Cardiac Output; D002319:Cardiovascular System / Q000187:drug effects / Q000503:physiopathology*; D004562:Electrocardiography; D015738:Famotidine / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006635:Histamine H2 Antagonists / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D009200:Myocardial Contraction; D010047:Ovalbumin / Q000276:immunology; D013318:Stroke Volume
D001562:Benzimidazoles; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D015738:Famotidine; D016589:Astemizole; D010047:Ovalbumin